What Nicorette Microtab Treats: Main Uses and Benefits

The primary therapeutic role of Nicorette Microtab is to provide essential support for smoking cessation by playing a role in managing the core condition of nicotine dependence. It helps to relieve and/or supports management of craving and nicotine withdrawal symptoms. The therapeutic role is aligned with guidance for this pharmacological class.

This replacement therapy is applied across domains where additional symptomatic support is needed to manage the physical and psychological manifestations that characterize early abstinence. The medication is commonly used to help with nicotine dependence, the relief of craving, and the broader management of withdrawal symptoms.

“The supportive therapeutic benefit may assist patients to cope more steadily during difficult episodes, which supports general well-being during symptomatic phases.”

Managing Acute Craving and Withdrawal

This medication is primarily used to address the most urgent symptom of dependence: the intense, sudden acute craving to use tobacco. It is relevant in contexts involving heightened systemic burden associated with abstinence, and the Microtab may assist with supportive relief that helps ease the overall symptom burden associated with craving episodes. It is applied in contexts where functional strain and emotional tension manifest as heightened irritability, anxiety, and persistent difficulty concentrating. This contributes to easing the overall symptom load during periods of heightened symptoms.

---

Quick Fact	Detail
Primary Use	Nicotine dependence and smoking cessation
Symptom Focus	Acute craving, irritability, difficulty concentrating
Patient Benefit	Supports general well-being and aids symptom management

The eligibility for using Nicorette Microtab is strictly defined by regulatory documents, establishing three main categories of users: approved, contraindicated, and restricted.

Populations for Whom Use is Contraindicated

Classification	Population or Condition
Absolute Exclusion	Non-smokers or occasional smokers
Age Exclusion	Children under 12 years of age
Allergy	Known hypersensitivity to nicotine or any excipient
Cardiac Events	Recent myocardial infarction, unstable angina, or severe arrhythmia

Age-Related Eligibility Rules

Age Group	Eligibility Status
Adults (18+ years)	Approved for use to aid smoking cessation.
Adolescents (12-17 years)	Use is permitted only with advice from a healthcare professional.

Condition-Specific Limitations (Use with Caution)

Nicorette Microtab should only be used under medical guidance in the presence of severe renal or moderate/severe hepatic impairment, uncontrolled hyperthyroidism, phaeochromocytoma, active peptic ulcer disease, or diabetes mellitus. Use during pregnancy or lactation is permitted, but only on the advice of a healthcare provider who has assessed the risk against the dangers of continued smoking.

Interactions with other medicines and products

Official documentation concerning interactions with Nicorette Microtab primarily addresses the pharmacokinetic consequences of smoking cessation rather than direct drug-nicotine interactions. Tobacco smoke is a potent inducer of the CYP1A2 enzyme. When a person stops smoking, this induction is removed, leading to a reduction in the metabolic clearance of co-administered medicines that are substrates of this enzyme.

This pharmacokinetic change can result in increased plasma concentrations of these medicines. This is clinically significant for drugs with a narrow therapeutic window, including Theophylline, Tacrine, Clozapine, Fluvoxamine, and certain others like Imipramine and Olanzapine.

Category	Documented Interaction Profile
Pharmacokinetic Effect	Reduced clearance of CYP1A2 substrates due to cessation of smoking.
Pharmacodynamic Effect	Possible enhancement of the haemodynamic effects of Adenosine.

In a population-specific context, patients with Diabetes Mellitus who stop smoking may require a lower dose of Insulin due to altered physiological factors. Regulatory information does not strictly contraindicate specific medicinal product combinations with Nicorette Microtab.

How Nicorette Microtab Works: Mechanism of Action

The Nicorette Microtab delivers nicotine, which acts on specific biological targets to modulate physiological responses. This pharmacodynamic effect begins upon absorption of nicotine into the systemic circulation.

---

Modulating Receptor-Mediated Signaling

Nicotine functions as an agonist at specific subtypes of nicotinic acetylcholine receptors (nAChRs), which are distributed across the central and peripheral nervous systems. The binding of nicotine to these receptors initiates a conformational change that causes ion channel opening. Subsequent and persistent binding leads to receptor desensitization and inactivation, which alters neuronal excitability and subsequent signaling sequences.

---

Influencing Neurotransmitter Systems

The activation and desensitization of nAChRs indirectly modulates the release kinetics of several key neurotransmitters in various brain regions. This modification of early molecular steps supports the regulation of processes driven by distinct signaling patterns. This cascade contributes to the attenuation of dysregulated physiological and cognitive signaling.

---

Shifting Toward Regulatory Control

The mechanism influences pathways involved in feedback regulation within the nervous system. This action contributes to a more regulated state within targeted pathways by modulating elevated mediator activity. This supports the restoration of balanced regulatory control within affected systems.

How to Use Nicorette Microtab

The administration of Nicorette Microtab is governed by standardized instructions. This product is formulated as a 2 mg sublingual tablet, designated for use under the tongue.

Administration Method and Dosing

The sublingual route is mandatory for the administration of the Microtab; the tablet must be placed directly under the tongue and allowed to dissolve slowly, a process that typically takes about 30 minutes. The product must not be chewed or swallowed.

The dosing protocol dictates an as-needed, intermittent usage pattern. For most adults, the standard dose is one 2 mg tablet used every one to two hours, up to a mandated maximum of 40 tablets per day (80 mg of nicotine). Individuals classified as heavy smokers may begin with two 2 mg tablets simultaneously every 1 to 2 hours.

Treatment Duration and Reduction

The overall treatment structure is time-limited. The initial phase of full dose use is typically maintained for up to three months. The medication is intended for use during a determined attempt to achieve complete smoking cessation.

Following the initial period, a gradual reduction (tapering) in the number of tablets consumed daily is required to complete the treatment course. The protocol specifies that treatment should be stopped when the daily consumption is consistently reduced to one or two tablets. Use beyond six to nine months is generally not recommended without further professional assessment.

Age-Specific Rules

Adolescents aged 12 to 18 years follow the standard adult dosing schedule and are subject to the same daily maximum dose. The product is not recommended for use in children under 12 years of age.

Nicorette Microtab: Recent Clinical Evidence

Clinical research evaluates the use of Nicorette Microtab, a type of fast-acting nicotine replacement therapy (NRT), as an aid for smoking cessation. The primary body of evidence comes from Randomized Controlled Trials (RCTs) and systematic reviews.

Efficacy and Quit Rates

Comprehensive meta-analyses, including those by the Cochrane Collaboration, suggest that all licensed forms of NRT increase the likelihood of successfully quitting smoking compared to placebo or no intervention. Specifically, the chances of stopping smoking are increased by approximately 50% to 70% with NRT use. The sublingual tablet is classified as a fast-acting NRT that delivers nicotine primarily through the oral mucous membranes.

• One randomized, placebo-controlled trial evaluating the 2mg sublingual tablet reported that participants using the active treatment achieved higher rates of abstinence compared to the placebo group at six months.

Comparison with Other NRT Forms

Limited evidence suggests no definitive difference in effectiveness between the different single forms of fast-acting NRT (e.g., gum, lozenge, microtab, inhaler). However, high-quality evidence supports that combination NRT (using a patch for steady nicotine supply plus a fast-acting form like the microtab for acute cravings) is associated with higher long-term quit rates than using a single form alone.

Safety and Tolerability Profile

NRT products are generally considered safe. The most common adverse effects observed in clinical trials for the Nicorette Microtab relate to the administration site due to its action on the oral mucosa. These include irritation or soreness in the mouth and throat, headache, and hiccups. Serious adverse events are rare. Regulatory bodies caution that doses of nicotine tolerated by adult smokers may pose severe toxicity risks to children.

Key Studies & References National Institute for Health and Care Excellence (NICE) Guideline: Smoking: stopping in adults and young people

Common questions about Nicorette Microtab (FAQ)

Q: How should I store the Nicorette Microtab to keep it effective?

Official product information states that the sublingual tablets should be stored at a temperature that does not exceed 30 C. To maintain the product's stability and effectiveness, it should be kept in the original container to protect it from moisture and light. Furthermore, to prevent accidental poisoning, the product must be kept out of the sight and reach of children.

---

Q: How long does it usually take for the tablet to dissolve under my tongue?

The administration instructions specify that the tablet must be placed under your tongue and allowed to dissolve slowly. This process, which facilitates the absorption of nicotine through the mouth lining, typically takes about 30 minutes to complete.

---

Q: What happens if I chew or swallow the microtab?

The Nicorette Microtab is formulated only for sublingual use (under the tongue), and the tablet should not be chewed or swallowed. Swallowing the tablet can cause the nicotine to be released into your digestive system instead of being absorbed efficiently. This may increase the likelihood of experiencing common side effects like hiccups, an upset stomach, or indigestion.

---

Q: Is the microtab more effective than other forms of NRT like the patch or gum?

Reviews that inform regulatory guidelines indicate that all single forms of Nicotine Replacement Therapy (NRT) are similarly effective in helping a person stop smoking when used correctly. Combination NRT (such as a patch plus a fast-acting form like the microtab) is cited in research as being associated with higher success rates compared to using a single form of NRT alone.

---

Q: What should I do if I forget to take a dose?

Nicorette Microtab is designed to be used as needed when a craving for a cigarette occurs. Guidelines for similar products advise that if a dose is missed or a craving passes, it is advised not to take extra tablets to make up for a missed one. Instead, continue using the microtabs as required for the next craving, while staying within the maximum daily allowance.

---

Q: How long am I supposed to use the Microtab before stopping?

According to official product information, the initial phase where the full dose is used is typically maintained for up to three months. Use beyond 9 months is not generally recommended and would require professional assessment.

---

Q: How do I know if the Nicorette Microtab is working for me?

The microtab is designed to relieve nicotine withdrawal symptoms and reduce the cravings associated with stopping tobacco use. The effectiveness is indicated by a user's ability to successfully reduce their smoking or achieve complete cessation. Official studies show the product increases the likelihood of successfully quitting smoking.

---

Q: Can I drink coffee, juice, or other liquids while the microtab is dissolving?

Official instructions for this type of oral NRT recommend avoiding eating or drinking anything for 15 minutes before and during the use of the sublingual tablet. This is particularly important for acidic beverages (like fruit juices or coffee), which may interfere with the proper absorption of nicotine across the lining of the mouth.

---

Q: What should I do with the used or expired tablets?

To ensure environmental safety, official guidelines state that any unused, unwanted, or expired tablets must be disposed of in accordance with local requirements for pharmaceutical waste. Medicines must not be placed in household waste or wastewater.

The official regulatory guidelines dictate specific conditions for storing and disposing of Nicorette Microtab to ensure product stability and safety. The sublingual tablets must be stored at a temperature not exceeding 30 C to maintain the 3-year shelf life. It is mandatory to keep the product out of the sight and reach of children, as nicotine doses tolerated by adults can be fatal to children. For stability, the medication must be stored in the original container to protect it from moisture and light.

Disposal

Disposal instructions state that any unused or expired product must be handled in accordance with local requirements for pharmaceutical waste. Medicines should not be disposed of via household waste or wastewater.